Meyka Pro banner
Pro-Dex, Inc.

Pro-Dex, Inc. (PDEX) Stock Overview

Explore Pro-Dex, Inc.’s financial performance, market position, analyst ratings, and future outlook.

PDEX●NASDAQ
HealthcareMedical - Instruments & Supplies
$62.21
$0.59(0.94%)
U.S. Market opens in 12h 57m

Pro-Dex, Inc. (PDEX)

Meyka AI Score

Z

Key Financials

Market Cap198.6M
P/E Ratio14.65
EPS (TTM)$4.13
ROE0.31%
Fundamental Analysis

AI Price Forecasts

1 Month$66.31
3 Months$73.08
1 Year Target$64.66

PDEX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Pro-Dex, Inc. (NASDAQ: PDEX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Pro-Dex, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PDEX on the NASDAQ shows an RSI of 39.72, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $64.66 for the NASDAQ listing.

Key metrics behind Pro-Dex, Inc.'s NASDAQ-traded stock include a P/E ratio of 14.65 and a market capitalization of 198.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of PDEX on the NASDAQ.

Price Performance (NASDAQ: PDEX)

1-Day Change
-0.94%
5-Day Change
-6.59%
1-Month Change
-6.32%
3-Month Change
4.08%
6-Month Change
27.04%
Year-to-Date (YTD) Change
61.67%
1-Year Change
79.07%
3-Year Change
300.45%
5-Year Change
150.34%
All-Time (Max) Change
285.68%

Contact Information

949 769 3200
2361 McGaw Avenue, Irvine, CA, 92614

Company Facts

2,040 Employees
IPO DateAug 7, 1986
CountryUS
Actively Trading

Frequently Asked Questions